【腎上腺素】結合RHML模型與分子動力學，識別臨床標靶「β2AR」異位點與調節機制

 【腎上腺素】結合RHML模型與分子動力學，識別臨床標靶「β2-腎上腺素受體(β2AR)」異位點與調節機制

 文章出處  

Nature Communications 

 

 原文標題  

Integrative residue-intuitive machine learning and MD Approach to Unveil Allosteric Site and Mechanism for β2AR 

 

 文章序號  

6287 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.